These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4761483)

  • 1. [Study of the effect of certain pharmacological agents on tardive dyskinesias and the rabbit syndrome].
    Jus K; Jus A; Gautier J; Villeneuve A; Pires P; Pineau R; Villeneuve R
    Vie Med Can Fr; 1973 Sep; 2(9):871-5. PubMed ID: 4761483
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome.
    Jus K; Jus A; Gautier J; Villeneuve A; Pires P; Pineau R; Villeneuv R
    Int J Clin Pharmacol; 1974 Mar; 9(2):138-45. PubMed ID: 4827556
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J; Floreánová L; Polák L
    Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia.
    Sovner R; Dimascio A
    Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992
    [No Abstract]   [Full Text] [Related]  

  • 6. Polygraphic profile of oral tardive dyskinesia and of rabbit syndrome: for quantitative and qualitative evaluation.
    Jus K; Jus A; Villeneuve A
    Dis Nerv Syst; 1973 Jan; 34(1):27-32. PubMed ID: 4350828
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic approaches to tardive dyskinesia. A review of the literature.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E; Christodoulides H
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 11. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of phenothiazine drug intoxication with benztropine.
    Bellman MH
    Arch Dis Child; 1974 Aug; 49(8):664-5. PubMed ID: 4424791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of ponalid in the treatment of hyperkineses produced by neuroleptics].
    Wasik A
    Neurol Neurochir Psychiatr Pol; 1965; 15(6):917-20. PubMed ID: 5864788
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM; Smith JM
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA
    Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
    [No Abstract]   [Full Text] [Related]  

  • 17. Akathisia: a side effect to be remembered.
    Raskin DE
    Am J Psychiatry; 1972 Sep; 129(3):345-7. PubMed ID: 5053718
    [No Abstract]   [Full Text] [Related]  

  • 18. A middle ground in prophylactic antiparkinsonian medication.
    Huttenbach DE
    Am J Psychiatry; 1977 Jul; 134(7):820-1. PubMed ID: 17309
    [No Abstract]   [Full Text] [Related]  

  • 19. The rabbit syndrome. A peculiar extrapyramidal reaction.
    Villeneuve A
    Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.